Here are three quick notes:
1. The Cowen and Company 36th Annual Health Care Conference will take place on March 7 and run through March 9 in Boston.
2. The Future Leaders in the Biotech Industry Conference will take place on March 11 in New York City.
3. Innovate Biopharmaceuticals is a clinical stage biotechnology company focused on developing gastroenterology medicines. Innovate’s lead drug candidate, INN-202, is an oral peptide that has been shown to reduce clinical symptoms of celiac disease in multiple clinical trials testing more than 800 patients.
More articles on GI & endoscopy:
FDA to examine TOPAS System as treatment for female fecal incontinence — 5 things to know
GI physician leader to know: Dr. John Cello of UCSF Medical Center
Mayo Clinic to live-stream a colonoscopy to raise CRC screening awareness: 3 points’
